Duration: (1:13) ?Subscribe5835 2025-02-11T13:46:59+00:00
GSK lacking 'focused investment on R\u0026D,' says European pharmaceuticals analyst
(3:4)
GSK buys out Novartis in $13 billion shake-up - ANI News
(1:13)
Is GSK PLC Stock a Buy Now in 2024? | GlaxoSmithKline PLC (GSK) UK Stock Analysis | Full Valuation
(9:30)
Novartis and GSK swap assets in pharma industry reshape - economy
(56)
Novartis buys GSK's cancer drugs \u0026 other internatinoal headlines
(1:40)
Is GSK an Excellent Dividend Stock to Buy for Passive Income Investors | Dividend Stock Investing
(4:59)
GSK to Complete $13 Billion Buyout of Novartis’ Stake in Consumer Health Business
(3:5)
Big changes at Novartis include GSK asset swap - economy
(36)
Unilever GSK Consumer Healthcare Bid | My Thoughts \u0026 Facts
(8:43)
Big pharma: GSK beats forecasts, but Novartis lags
(1:14)
Why are Glaxo Shares Cheap?
(1:17)
GSK buys Novartis stake in consumer health care venture for $13-billion
(2:3)
Passive Income: What a £500K Dividend Portfolio \u0026 Premium Bonds Paid Me This Month: January 2025
(8:9)
GLAXOSMITHKLINE PHARMACEUTICALS SHARE LATEST NEWS 6FEB'25/GSK PHARMA STOCK LATEST ANALYSIS
(4:29)
Why I Quit Dividend Investing
(16:28)
Pharma results, Crest Nicholson \u0026 Compass Group: The Companies and Markets Show
(36:39)
Get Paid Dividends Every Month From Just 3 UK Companies
(5:53)
[2022] Pass the GSK Interview | GSK Video Interview
(17:16)
Chemical Space: Opportunities Amid Tariff Changes, Mayuresh Joshi's Top Picks From This Sector
(18:32)
Investors Are Preparing For Something Big In The S\u0026P
(10:25)
GDXJ is CHEAP, Nasdaq vs GOLD, URANIUM $400/lbs, RE Cycle, Commodities to STOCKS, COPPER, S\u0026P 500
(29:7)
Is GlaxoSmithKline (GSK) Stock a buy?
(13:5)
Is GSK Stock a Buy Now!? | GSK Stock Analysis Deep Dive! |
(15:40)
GSK: Financial Analysis - GlaxoSmithCline is in the news and under pressure - time to buy?
(18:40)
Pharmaceutical giant GlaxoSmithKline closer to splitting in two
(1:25)
Aspen to Buy Drug Portfolio from GSK
(6:6)
GSK Buys U.S. Pharma For $57M - Nov 4
(1:52)
Is GlaxoSmithKline a Buy Now!? | GSK Stock Analysis
(5:28)
Our global commitment to oncology
(2:36)